Certified by Founder
Lodge
Adcendo
start up
Denmark
- Copenhagen, Capital Region of Denmark
- 26/11/2024
- Series B
- $135,000,000
Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need.
The company was founded in 2017 in Copenhagen, as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen.
- Industry Biotechnology Research
- Website https://adcendo.com/
- LinkedIn https://www.linkedin.com/company/adcendo/
Kin Health | $9,000,000 | (May 20, 2026)
Scope AI | $20,000,000 | (May 20, 2026)
Leadbay (YC F25) | $4,300,000 | (May 20, 2026)
Hellbender Inc. | $12,500,000 | (May 20, 2026)
Rely | $4,500,000 | (May 20, 2026)
bunch | $35,000,000 | (May 20, 2026)
Vital Signals | $15,000,000 | (May 20, 2026)
viktor.com | $75,000,000 | (May 20, 2026)
Brami Inc. | $33,000,000 | (May 20, 2026)
Benji | $6,250,000 | (May 20, 2026)
Hacktron AI | $2,900,000 | (May 19, 2026)
Elliptic | $120,000,000 | (May 19, 2026)